Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,196 results that match your search.22,196 results
  • Singapore's patent rules have been amended this year to recognize search and examination reports and patents issued by the Japanese Patent Office (JPO) in the grant process of Singapore patents. Singapore patent applications with a priority filing date on or after August 15 2002, may rely on JPO search and examination reports and granted patents in place of local search and examination.
  • In July 2000, the Korean Supreme Court handed down its first decision specifically stating the requirements for the doctrine of equivalents. Afterwards, many other relevant precedent cases have also been decided in a rather short period of time.
  • It is no great news to report that bureaucratic delays continue to dog the new Trademarks Act passed by the Indian parliament way back in 1999 with much TRIPs Agreement-compliant hype and fanfare. The latest to join the game of hurdles is a writ filed before the High Court of Delhi, challenging certain aspects of the new law.
  • An action to revoke its patent on the drug Videx EC threatens to limit further Bristol-Myers Squibb's (BMS) rights to sell Aids medicines in Thailand. Three Aids patients and the Foundation for Consumers, a local group, claim that the US pharmaceutical company did not invent the drug and so should not be allowed to own the rights to it in Thailand. According to the plaintiffs, the drug is a product of collaboration between BMS and the US National Institutes of Health (NIH).
  • In a series of four decisions rendered recently by the German Federal Supreme Court (BGH), the Court considered the extent to which the doctrine of equivalents applies to patent claims reciting numerical ranges: BGH GRUR 2002, 515 - Schneidmesser I (in English, Cutting Knife I); 519 - Schneidmesser II; 523 - Custodiol I; 527 - Custodiol II.
  • Pharma company AstraZeneca has stopped three generics from launching rival versions of its multi-billion dollar drug Prilosec in the US. But a fourth generic company is free to manufacture its own version of the drug.
  • One might have thought that the question of the exhaustion of trade marks in the European Economic Area (EEA) had been resolved, or at least stabilized, to a certain extent.
  • George W Bush The US government has moved to make generic drugs more widely available. In an announcement on October 22, President George W Bush said he would adopt key recommendations made by the FTC in its report into competition in the industry.
  • The company that brought you Popstars and other global TV brands is now launching a licensing arm. Ingrid Hering finds out why
  • In part two of the World IP Survey, MIP reveals the leading trade mark and copyright firms in 25 jurisdictions, and specialists from the leading firms discuss current trends